Fewer People Dying From Colon Cancer
Luckily fewer people are dying from Colon Cancer each year in this is due to good education and early detection of those who are potentially at risk. How do you know if you are at risk? Well if someone in your immediate family has had colon cancer you might be more susceptible.
If you are over 45 years old and you have found you are passing blood in your stool then you may want to get checked out. Then or women with iron deficiency used can a Read More...
Some Answers To Colon Cancer Questions
1. What is colon cancer?
Cancer is a disease which can affect cells from all organs. The colon cancer affects the cells of the colon, determining them to proliferate in an uncontrollable way. This mass of abnormal cells will form a tumor inside the colon. The cancer of the intestine is quite frequent and two thirds of this type of cancer is situated in the colon.
2. Who can develop colon cancer?
You are at risk of developing colon cancer if yo Read More...
Colon Cancer Treatments - The Three Most Common Procedures
If you have been diagnosed with colon cancer, then your next step is to think about treatment. Treatment options vary and will be determined by the stage of colon cancer and the location of the cancer. Your oncologist will be able to give you the best advice on which treatment option is right for you. This article is going to explain three of the most common treatments for colon cancer. Keep reading to gain a valuable education.
Surgery is a Sta Read More...
Curbing colon cancer WITH early screening, detection and treatment, incidences of colon cancer will be reduced. Unfortunately, there are still many who do not have access to such screening due to lack of awareness or financial problems. Read More...
Identified a cause of resistance to colon cancer treatment ( IMIM (Hospital del Mar Research Institute) ) Spanish scientists point to an acquired mutation during treatment as the causative mechanism of therapeutic failure.This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer. Read More...
Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects Updated with Thursday's stock price, current side effect data on regorafenib. ="Scripts/swfobje ct_modified.js" type="text/javasc ript"if !IE--endif--Content on this page requires a newer version of Adobe Flash Player. if !IE--endif-- EMERYVILLE, Calif. (TheStreet) --Treatment with Bayer's experimental drug regorafenib prolonged the lives of patients with advanced colon cancer by about six weeks ... Read More...
Winning Against Cancer with Safe and Effective Treatments The marathon battle against cancer continues but we are winning. New statistics from the American Cancer Society show the number of cancer-related deaths has decreased by about 23% in men and 15% in women since 1990. These promising reductions in the mortality rate are most apparent in lung, colon, breast, and prostate cancers, the most [...] Read More...
Study identifies a cause of resistance to colon cancer treatment Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR. Read More...
New Test May Help Reduce Lung Cancer Deaths (Ivanhoe Newswire)-- Lung cancer kills more then 150,000 Americans and 1.4 million people worldwide every year. More people die from lung cancer each year then those with breast, colon, and prostate cancers combined. An international team l ... Read More...